ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2-ABC) with aggressive disease criteria

被引:7
作者
de la Haba Rodriguez, J. [1 ]
Cortes, J. [2 ]
Di Cosimo, S. [3 ]
Lopez-Barajas, I. Blancas [4 ]
Cortez Castedo, S. P. [5 ]
Lopez, A. [6 ]
Lopez-Miranda, E. [7 ]
Pla Juher, H. [8 ]
Albacar Miro, C. R. [9 ]
Ponce, J. [10 ]
Caranana Ballerini, V. [11 ]
Paris Bouzas, L. [12 ]
Valero Arbizu, M. [13 ]
Ruiz Borrego, M. R. B. [14 ]
Iranzo, V. [15 ]
Garrido, A. [16 ]
Alcala-Lopez, D. [17 ]
Mina, L. [17 ]
Garcia Mosquera, J. J. [18 ]
Llombart Cussac, A. [19 ]
机构
[1] Hosp Univ Reina Sofia, Oncol, Cordoba, Spain
[2] IBCC, Barcelona, Spain
[3] Fdn IRCCS Ist Nazl Tumori, Appl Res & Technol Dev Dept, Milan, Italy
[4] Hosp Clin San Cecilio, Oncol Dept, Granada, Spain
[5] Complejo Hosp Ruber Juan Bravo, Med Oncol Dept, Madrid, Spain
[6] Hosp Leon, Complejo Asistencial Univ Leon, Oncol, Leon, Spain
[7] Hosp Univ Ramon y Cajal, Oncol, Madrid, Spain
[8] ICO Girona Inst Catala Oncol Girona, Med Oncol Dept, Girona, Spain
[9] Hosp Univ St Joan Reus, Oncol Dept, Reus, Spain
[10] Hosp Gen Univ Dr Balmis, Med Oncol Dept, Alicante, Spain
[11] Hosp Arnau Vilanova, Oncol, Valencia, Spain
[12] CHUAC, Oncol Med, La Coruna, Spain
[13] Hosp Quironsalud Sagrado Corazon, Oncol, Seville, Spain
[14] Hosp Univ Virgen del Rocio, Oncol Dept, Seville, Spain
[15] CHGUV, Oncol Dept, Valencia, Spain
[16] MEDSIR Med Scientia Innovat Res, Oncol, Barcelona, Spain
[17] MEDSIR Med Scientia Innovat Res, Sci Dept, Barcelona, Spain
[18] IOR Inst Oncol Dr Rosell, Med Oncol Dept, Barcelona, Spain
[19] Hosp Arnau Vilanova, Oncol Dept, Valencia, Spain
关键词
D O I
10.1016/j.annonc.2024.08.2261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA23
引用
收藏
页码:1215 / 1216
页数:2
相关论文
empty
未找到相关数据